Skip to content

2023 | Topic: Hepatitis B

EASL response to the European Commission Call for evidence for cancer prevention – action to promote vaccination against cancer-causing

EASL welcomes the initiative of the European Commission to propose actions to increase the uptake of vaccination against the Hepatitis B virus and human papillomaviruses. In its response, EASL calls on the EU Member States to prioritise key actions, especially to upscale HBV vaccination rates, by encouraging Member States to implement stronger national strategies and to update National Cancer Control Plans with HBV vaccination included in routine vaccination schedules.

Back To Top